Furthermore, suppression of ectopic FGFR1 signaling reduces inflammation in the tumor microenvironment and reverses metabolic reprogramming of cancer cells, both of which have profound effects on anti-cancer chemotherapies and anti-checkpoint treatment. Here, FGFR1 is linked to cancer.